"The decision to close the site is based on an assessment of its long-term viability and its ability to achieve the needed production. There has practically been no production activity at this plant since 2013...," a Pfizer spokesperson said.
The spokesperson added that the closure of the facility will not impact supply of any of the company's medicines to patients.
The plant, which employed 212 workers, had offered a voluntary retirement scheme (VRS) last year. This was taken up by as many as 132 workmen, the spokesperson said.
In a filing to the BSE, Pfizer said, "the company has intimated the concerned authorities that it intends to effect closure of its plant situated at Thane Belapur Road,... Navi Mumbai with effect from September 16, 2015".
The Thane plant was commissioned in the 1960s. It had produced a number of medicines for both domestic and international markets.
Shares of Pfizer today closed at Rs 2,105.20 per scrip on BSE, down 0.26 per cent from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
